Suchergebnisse - "El Kassas, Mohamed"

PubPharm (14)

1

A randomized-controlled trial of SOF/VEL/VOX with or without ribavirin for retreatment of chronic hepatitis C

enthalten in: Journal of hepatology | 2023

von El-Kassas, M. | Emadeldeen, M. | Hassany, M. | +6

2

Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™

enthalten in: Journal of viral hepatitis | 2023

von Younossi, Z. | Yu, M. | Yilmaz, Y. | +23

3

Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world : Data from the global liver registry

enthalten in: Journal of viral hepatitis | 2022

von Younossi, Z. | Yu, M. | El-Kassas, M. | +21

4

Sofosbuvir/ledipasvir in combination or nitazoxanide alone are safe and efficient treatments for COVID-19 infection : A randomized controlled trial for repurposing antivirals

enthalten in: Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology | 2022

von Medhat, M. | El-Kassas, M. | Karam-Allah, H. | +17

5

High success rates for the use of ombitasvir/paritaprevir/ritonavir containing regimens in treatment of naïve and experienced chronic hepatitis C genotype 4 : Real world results

enthalten in: Journal of medical virology | 2022

von El Kassas, M. | Alboraie, M. | Omar, H. | +8

6

Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis

enthalten in: European journal of gastroenterology & hepatology | 2021

von El Kassas, M. | Abdeen, N. | Omran, D. | +14

7

Renal profile of chronic hepatitis C patients with sofosbuvir-based therapy

enthalten in: Infection | 2020

von El-Sayed, M. | Abdellatif, Z. | Elsharkawy, A. | +6

8

Retreatment of chronic hepatitis C patients who failed previous therapy with directly acting antivirals : A multicenter study

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020

von El Kassas, M. | Alboraie, M. | El Badry, M. | +15

9

High success rates for the use of sofosbuvir/ombitasvir/paritaprevir/ritonavir + ribavirin and sofosbuvir/simeprevir/daclatasvir + ribavirin in retreatment of chronic hepatitis C infection after unsuccessful sofosbuvir/daclatasvir therapy : a real-life experience

enthalten in: Archives of virology | 2020

von Said, E. | Abdulaziz, B. | El Kassas, M. | +3

RetractionIn: Arch Virol. 2024 Feb 13;169(3):45. - PMID 38349452

10

Liver stiffness measurements and FIB-4 are predictors of response to sofosbuvir-based treatment regimens in 7256 chronic HCV patients

enthalten in: Expert review of gastroenterology & hepatology | 2019

von Abdel Alem, S. | Elsharkawy, A. | El Akel, W. | +13